CAR T

Danielle Blud1, Patricia Rubio-Reyes1, Rachel Perret1

  • 1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.

Seminars in hematology
|August 2, 2024
PubMed
概括

化学抗原受体 (CAR) T细胞疗法可以改进,以更好地治疗癌症. 基因工程允许增强CAR T细胞,提高安全性和有效性,特别是在固体瘤中.